Literature DB >> 11239917

Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu(2+) complex.

S H Chen1, S H Liu, Y C Liang, J K Lin, S Y Lin-Shiau.   

Abstract

Disulfiram is frequently used in the treatment of alcoholism. In this study, we found that CuCl(2) (1-10 microM), but not other metal ions (Fe(2+), Zn(2+), Pb(2+)), markedly potentiated disulfiram-induced cytotoxicity by 440-fold in primary astrocytes. Thus, the molecular mechanisms of the cytotoxic effects induced by the disulfiram-Cu(2+) complex were explored. The changes in morphology (nuclear condensation and apoptotic body formation) and hypodiploidy of DNA suggested that the disulfiram-Cu(2+) complex induced an apoptotic process. Our studies of the death-signaling pathway reveal that decreased mitochondrial membrane potential, increased free radical production, and depletion of non-protein-thiols (glutathione) were involved. The disulfiram-Cu(2+) complex activated c-Jun-amino-terminal kinase (JNK) and caspase-3 followed by poly (ADP-ribose) polymerase degradation in a time-dependent manner. Moreover, the cellular Cu content was markedly increased and the copper chelator bathocuproine disulfonate abolished all of these cellular events, suggesting that Cu(2+) is essential for death signaling. The antioxidants N-acetylcysteine and vitamin C also inhibited the cytotoxic effect. Thus, we conclude that the disulfiram-Cu(2+) complex induces apoptosis and perhaps necrosis at a late stage mediated by oxidative stress followed by sequential activation of JNK, caspase-3 and poly (ADP-ribose) polymerase degradation. These findings imply that the axonal degeneration and neurotoxicity observed after the chronic administration of disulfiram are perhaps, at least in part, due to the cytotoxic effect of the disulfiram-Cu(2+) complex formed endogenously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239917     DOI: 10.1016/s0014-2999(01)00792-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Uptake and Toxicity of Copper Oxide Nanoparticles in C6 Glioma Cells.

Authors:  Arundhati Joshi; Wiebke Rastedt; Kathrin Faber; Aaron G Schultz; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2016-08-03       Impact factor: 3.996

Review 2.  Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.

Authors:  Maricela Viola-Rhenals; Kush R Patel; Laura Jaimes-Santamaria; Guojun Wu; Jinbao Liu; Q Ping Dou
Journal:  Curr Med Chem       Date:  2018-02-12       Impact factor: 4.530

3.  Copper signaling axis as a target for prostate cancer therapeutics.

Authors:  Rachid Safi; Erik R Nelson; Satish K Chitneni; Katherine J Franz; Daniel J George; Michael R Zalutsky; Donald P McDonnell
Journal:  Cancer Res       Date:  2014-10-15       Impact factor: 12.701

Review 4.  New concepts in the mechanism of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao; K S Panickar
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

5.  Ascorbate and thiol antioxidants abolish sensitivity of yeast Saccharomyces cerevisiae to disulfiram.

Authors:  Magdalena Kwolek-Mirek; Renata Zadrag-Tecza; Grzegorz Bartosz
Journal:  Cell Biol Toxicol       Date:  2011-08-25       Impact factor: 6.691

6.  A Comparative Cytotoxic Evaluation of Disulfiram Encapsulated PLGA Nanoparticles on MCF-7 Cells.

Authors:  Hamidreza Fasehee; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed-Hamidollah Ghaffari; Shahab Faghihi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

7.  Hydroxycobalamin catalyzes the oxidation of diethyldithiocarbamate and increases its cytotoxicity independently of copper ions.

Authors:  M E Solovieva; Yu V Shatalin; V V Solovyev; A V Sazonov; V P Kutyshenko; V S Akatov
Journal:  Redox Biol       Date:  2018-09-25       Impact factor: 11.799

8.  Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.

Authors:  Haowen Li; Biao Liu; Hui Ao; Jingxin Fu; Yian Wang; Yue Feng; Yifei Guo; Xiangtao Wang
Journal:  J Nanobiotechnology       Date:  2020-01-06       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.